<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03535519</url>
  </required_header>
  <id_info>
    <org_study_id>Reuma-01-2017</org_study_id>
    <nct_id>NCT03535519</nct_id>
  </id_info>
  <brief_title>Rheumatoid Arthritis Response to Methotrexate</brief_title>
  <official_title>Rheumatoid Arthritis Ultrasound Response to Methotrexate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Juan Carlos Nieto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nordic Pharma SAS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Gregorio Mara침on</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational and prospective study of the ultrasound response to methotrexate in rheumatoid
      arthritis patients who started methotrexate
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rheumatoid arthritis patients with active disease who their rheumatologist prescribe
      methotrexate as a treatment will be included.

      Patients will participate in a prospective and observational study in which the response to
      methotrexate will be performed by ustrasound (US) of joints and tendons The main objective of
      the study is the change in B mode and Doppler mode US after 24 weeks of methotrexate
      treatment
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 31, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ultrasound response</measure>
    <time_frame>Basal and at 6 months</time_frame>
    <description>Change in B mode and Doppler mode sinovitis and tenosynovitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical response</measure>
    <time_frame>Basal and 6 months</time_frame>
    <description>Change in disease activity measured by DAS28, CDAI and SDAI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional response</measure>
    <time_frame>Basal and 6 months</time_frame>
    <description>Change in functional status measured by HAQ</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methotrexate</intervention_name>
    <description>standard of care treatment with methotrexate</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Rheumatoid arthritis fulfilling EULAR criteria with active disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Active rheumatoid arthritis fulfilling EULAR criteria.

          -  Prescription of methotrexate by a rheumatologist.

          -  Informed consent signed by the patient.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Carlos Nieto Gonz치lez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Maranon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Carlos Nieto Gonz치lez, PhD</last_name>
    <phone>+34637723549</phone>
    <email>juancarlos.nietog@gmail.com</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Mara침on</investigator_affiliation>
    <investigator_full_name>Juan Carlos Nieto</investigator_full_name>
    <investigator_title>Rheumatology consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methotrexate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

